Interventional approaches for resistant hypertension

Current Opinion in Nephrology and Hypertension

Volumn 21, Issue 5, 2012, Pages 475-480

  Davidson, Andrew C ^a   Bisognano, John D ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

baroreflex activation therapy; renal sympathetic denervation; resistant hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ABLATION THERAPY; ADRENERGIC SYSTEM; ANTIHYPERTENSIVE THERAPY; BACKACHE; BLOOD PRESSURE REGULATION; DRUG EFFICACY; DRUG SAFETY; FALSE ANEURYSM; GASTROINTESTINAL SYMPTOM; HUMAN; KIDNEY DENERVATION; KIDNEY NERVE; MORBIDITY; MORTALITY; NERVE INJURY; PARESTHESIA; PRESSORECEPTOR; PRIORITY JOURNAL; PULSE GENERATOR; RADIOFREQUENCY ABLATION; RESISTANT HYPERTENSION; RESPIRATORY TRACT DISEASE; REVIEW; SIGNAL TRANSDUCTION; SWEATING; SYMPATHECTOMY; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE; URINARY TRACT INFECTION; WOUND COMPLICATION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CATHETER ABLATION; HUMANS; HYPERTENSION; SYMPATHECTOMY; TREATMENT OUTCOME;

EID: 84865412144     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e328356d004     Document Type: Review

References (30)

1. Daugherty SL, Powers JD, Magid DJ, et al. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation 2012; 125: 1635-1642.
2. Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008; 51:1403-1419.
3. Kelly T, Yang W, Chen CS, et al. Global burden of obesity in 2005 and projections to 2030. Int J Obes 2008; 32:1431-1437.
4. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365:217-223. (Pubitemid 40138015)
5. Krum H, Barman N, Schlaich M, et al. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 2011; 57:911-917.
6. Bisognano JD, Bakris G, Nadim MK, et al. Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled Rheos pivotal trial. J Am Coll Cardiol 2011; 58:765-773.
7. Sarnoff SJ, Gilmore JP, Brockman SK, et al. Regulation of ventricular contraction by the carotid sinus. Its effect on atrial and ventricular dynamics. Circ Res 1960; 8:1123-1136.
8. Demattos AD, Levy MN, Ziesk EH. Response of the heart to increased peripheral resistance. Circulation Res 1963; 13:33-38.
9. Thrasher TN. Unloading arterial baroreceptors causes neurogenic hypertension. Am J Physiol Regul Integr Comp Physiol 2002; 282:R1044-R1053. (Pubitemid 34664556)
10. Thomas GD. Neural control of the circulation. Adv Physiol Educ 2011; 35:28-32.
11. Heesch CM. Reflexes that control cardiovascular function. Am J Physiol 1999; 277 (6 Pt 2):234-243.
12. Barajas L, Müller J. The innervation of the juxtaglomerular apparatus and surrounding tubules: a quantitative analysis by serial section electron microscopy. J Ultrastruct Res 1973; 43:107-132.
13. DiBona GF. Neural control of the kidney: past, present, and future. Hypertension 2003; 41:621-624.
14. Gewirtz JR, Bisognano JD. Catheter-based renal sympathetic denervation: a targeted approach to resistant hypertension. Cardiol J 2011; 18:97-102.
15. Schlaich MP, Lambert E, Kaye DM, et al. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension 2004; 43:169-175. (Pubitemid 38174169)
16. Kopp UC, Cicha MZ, Smith LA, et al. Renal sympathetic nerve activity modulates afferent renal nerve activity by PGE2-dependent activation of alpha1-and alpha2-adrenoceptors on renal sensory nerve fibers. Am J Physiol Regul Integr Comp Physiol 2007; 293:R1561-R1572. (Pubitemid 47535774)
17. Schlaich MP, Sobotka PA, Krum H, et al. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 2009; 361:932-934.
18. Grassi G. Sympathetic neural activation in hypertension. Am J Hypertens 2010; 23:1052-1060.
19. Illig KA, Levy M, Sanchez L, et al. An implantable carotid sinus stimulator for drug-resistant hypertension: surgical technique and short-term outcome from the multicenter phase II Rheos feasibility trial. J Vasc Surg 2006; 44:1213-1218.
20. Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-ofprinciple cohort study. Lancet 2009; 373:1275-1281.
21. Prochnau D, Lucas N, Kuehnert H, et al. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter. Euro Intervention 2012; 7:1077-1080.
22. Grimson KS, Orgain ES, Anderson B, et al. Results of treatment of patients with hypertension by total thoracic and partial to total lumbar sympathectomy, splanchnicectomy and celiac ganglionectomy. Ann Surg 1949; 129:850-871.
23. Esler MD, Krum H, Sobotka PA. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010; 376:1903-1909.
24. Bakris GL, Nadim MK, Haller H, et al. Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial. J Am Soc Hypertens 2012; 6:152-158.
25. Mahfoud F, Schlaich MP, Kindermann I, et al. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation 2011; 123:1940-1946.
26. Schlaich MP, Hering D, Sobotka P, et al. Effects of renal denervation on sympathetic activation, blood pressure, and glucose metabolism in patients with resistant hypertension. Front Physiol 2012; 3:10.
27. Schlaich MP, Straznicky N, Grima M, et al. Renal denervation: a potential new treatment modality for polycystic ovary syndrome? J Hypertens 2011; 29:991-996.
28. Witkowski A, Prejbisz A, Florczak E, et al. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension 2011; 58:559-565.
29. Bisognano JD, Kaufman CL, Bach DS, et al. Improved cardiac structure and function with chronic treatment using an implantable device in resistant hypertension: results from European and United States trials of the Rheos system. J Am Coll Cardiol 2011; 57:1787-1788.
30. Brandt MC, Mahfoud F, Reda S, et al. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol 2012; 59:901-909.